Jan 22 (Reuters) - CANTARGIA AB:
* EUROPEAN PATENT OFFICE CANCELS ORAL OPPOSITION PROCEEDINGS CONCERNING CANTARGIA‘S PATENT FOR HEMATOLOGICAL CANCERS
* ‍CANTARGIA‘S PATENT PROTECTION IN EUROPE IS EXPECTED TO REMAIN ESSENTIALLY UNCHANGED​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)
 